CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Holds a Bachelor's degree in Nursing from the Federal University of Mato Grosso (2019) and a Master's degree in Pharmacology from the State University of Campinas (2021). Currently pursuing a Ph.D. in Neuroscience at the Ribeirão Preto Medical School, University of São Paulo (FMRP/USP, 2021-2024), where he served as a Student Representative on the Program Coordination Committee (CCP, 2023-2024) and the Management Committee (CG/PROEX) of the Graduate Program in Neuroscience and Behavioral Sciences (2024).Since 2022, he has been a visiting researcher in the Department of Neuroscience and Mental Health at Carleton University, Ottawa, Canada, under the supervision of Dr. Argel Aguilar-Vales.He has been a full member of the Brazilian Association of Mental Health (Abrasme) since 2018 and the Brazilian Society of Pharmacology and Experimental Therapeutics (SBFTE) since 2020, where he has served as a coordinating member of SBFTE Jovem since 2024. Additionally, he has been a member of the American Society for Pharmacology and Experimental Therapeutics (ASPET) and the British Pharmacological Society (BPS) since 2023, as well as the International Society for Neurochemistry (ISN) since 2024. He is also a member of the Society for Neuroscience (SfN) and the Canadian Association for Neuroscience (CAN-ACN). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
There is a growing interest in the neural bases of behaviours associated with anxiogenic and depressive-like effects. Innovative studies focused on biochemical and pharmacological mechanisms of cannabinoids seem to be suitable for providing new therapeutic targets for mental disorders treatment. Brain-derived neurotrophic factor (BNDF) and rampamycin-target protein complex 1 (mTOR1) signa…
There is a growing interest in understanding neural behaviors associated with anxiety and depression. Innovative studies exploring the biochemical and pharmacological mechanisms of cannabinoids offer promising avenues for developing new therapeutic targets for mental disorders treatment. The rapamycin-target protein complex 1 (mTOR1) signaling pathway plays a crucial role in long-term str…
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Ongoing scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |